United Kingdom· GB-APID-7655711000001108
Amsidine 75mg/1.5ml solution for infusion ampoules and diluent
A amsacrine product containing amsacrine, registered in United Kingdom by Mercury Pharma Group Ltd. The same ATC class is registered in 10 of our 19 countries.
Checked against NHS dm+d (United Kingdom) on
Informational only — not a medical device.
Where it is registered
Amsacrine is registered in 10 of 19 countries.
Countries holding a registration under ATC L01XX01 (amsacrine), each read from that country’s own register.
- This record: United Kingdom, from NHS dm+d (United Kingdom)
- 5 of them publish a price we can compare per daily dose
Amsacrine · ATC L01XX01
10 / 19 countries
- Belgiumprice
- Denmark
- Finlandprice
- Franceprice
- Germany
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- United Kingdom
The record
At a glance
NHS dm+d (United Kingdom)- Active substance
- Amsacrine
- Manufacturer
- Mercury Pharma Group Ltd
- Country
- United Kingdom (GB)
- ATC code
- L01XX01
- ATC class
- Amsacrine
- Reimbursed
- Not published by this register
- Source register
- NHS dm+d (United Kingdom)
- Last checked
- September 13, 2026
Packs & prices · 1
- gtin5021691150053
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Amsacrine in 10 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- FinlandAmekrinEurocept International BV
- GermanyAmlyoEurocept International Bv
- NorwayAmlyoEurocept
- IcelandAmsalyoEurocept International B.V.
- NetherlandsAmsalyo 75 mg poeder voor concentraat voor oplossing voor infusieEurocept International B.V.
- BelgiumAmsidine 75 mg/1.5 mlEurocept International
- SwedenAmsalyo 75 mg Pulver till koncentrat till infusionsvätska, lösningEurocept International B.V.
- SpainAMEKRIN 75 MG/1,5 ML CONCENTRADO Y DISOLVENTE PARA CONCENTRADO PARA SOLUCION PARA PERFUSIONEurocept International B.V.
Authorised across Europe · EMA
The same active substance is authorised in 13 EEA countries. Names it is sold under:
- Austria · Amlyo
- Germany · Amlyo, Amsidyl
- Denmark · Amsalyo
- Finland · Amsalyo
- France · Amsalyo
- Croatia · Amlyo
- Ireland · Amsalyo
- Iceland · Amsalyo
- Italy · Amsalyo
- Luxembourg · Amsalyo
- Netherlands · Amsalyo
- Norway · Amsalyo
- Sweden · Amsalyo
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of NHS dm+d (United Kingdom). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/b01e9c47-a892-4350-9c45-b82713cc70a6 GET /v1/drugs/b01e9c47-a892-4350-9c45-b82713cc70a6?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"apid": "7655711000001108",
"desc": "Amsidine 75mg/1.5ml solution for infusion ampoules and diluent (Mercury Pharma Group Ltd)",
"form": "Solution for infusion",
"vpid": "19431511000001106",
"source": "dmd",
"vtm_id": "774596000",
"strength": "50 mg",
"substance": "Amsacrine",
"ingredient": "Amsacrine",
"supplier_code": "151601000001102"
}See everything about amsacrine.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.